Showing results (1531-1540 of 1,963) with videos related to

Sort By:
Pageof 197
RMD Open|March 27, 2020
Effects of ustekinumab on spondylitis-associated endpoints in TNFi-naïve active psoriatic arthritis patients with physician-reported spondylitis: pooled results from two phase 3, randomised, controlled trialsPhilip S Helliwell, Dafna D Gladman, Soumya D Chakravarty, et al.
RMD Open|July 30, 2021
Suitability for e-health of non-pharmacological interventions in connective tissue diseases: scoping review with a descriptive analysisValentin Ritschl, Ricardo J O Ferreira, Eduardo José Ferreira Santos, et al.
RMD Open|June 22, 2022
Low-dose CT hounsfield units: a reliable methodology for assessing vertebral bone density in radiographic axial spondyloarthritisMary Lucy Marques, Nuno Pereira da Silva, Desirée van der Heijde, et al.
RMD Open|June 17, 2022
Levelling the playing field of RMD research across Europe to address patients' needs: the emerging EULAR Research CentreKatja Reuter, Carina Haupt, Anna Molto, et al.
RMD Open|December 14, 2020
Predictors of renal damage in systemic lupus erythematous patients: data from a multiethnic, multinational Latin American lupus cohort (GLADEL)Cristina Reátegui-Sokolova, Manuel F Ugarte-Gil, Guillermina B Harvey, et al.
RMD Open|January 5, 2021
Temporomandibular disorders in patients with early rheumatoid arthritis and at-risk individuals in the Dutch population: a cross-sectional studyJohanna M Kroese, Catherine M C Volgenant, Wim Crielaard, et al.
RMD Open|May 29, 2021
CT-like images of the sacroiliac joint generated from MRI using susceptibility-weighted imaging (SWI) in patients with axial spondyloarthritisDominik Deppe, Kay-Geert Hermann, Fabian Proft, et al.
RMD Open|December 22, 2022
Treat-to-target in rheumatoid arthritis: a real-world study of the application and impact of treat-to-target within the wider context of patient management, patient centricity and advanced therapy use in EuropePeter C Taylor, Bruno Fautrel, Yves Piette, et al.
RMD Open|September 22, 2016
Post-traumatic arthritis: overview on pathogenic mechanisms and role of inflammationLeonardo Punzi, Paola Galozzi, Roberto Luisetto, et al.
RMD Open|February 5, 2022
Long-term safety and efficacy of upadacitinib or adalimumab in patients with rheumatoid arthritis: results through 3 years from the SELECT-COMPARE studyRoy Fleischmann, Eduardo Mysler, Louis Bessette, et al.
Pageof 197